194 related articles for article (PubMed ID: 24609902)
1. Osteosarcoma metastasis: prospective role of ezrin.
Zhang Y; Zhang L; Zhang G; Li S; Duan J; Cheng J; Ding G; Zhou C; Zhang J; Luo P; Cai D; Kuang L; Zhou Y; Tong L; Yu X; Zhang L; Xu L; Yu L; Shi X; Ke A
Tumour Biol; 2014 Jun; 35(6):5055-9. PubMed ID: 24609902
[TBL] [Abstract][Full Text] [Related]
2. Role of ezrin in osteosarcoma metastasis.
Ren L; Khanna C
Adv Exp Med Biol; 2014; 804():181-201. PubMed ID: 24924175
[TBL] [Abstract][Full Text] [Related]
3. The actin-cytoskeleton linker protein ezrin is regulated during osteosarcoma metastasis by PKC.
Ren L; Hong SH; Cassavaugh J; Osborne T; Chou AJ; Kim SY; Gorlick R; Hewitt SM; Khanna C
Oncogene; 2009 Feb; 28(6):792-802. PubMed ID: 19060919
[TBL] [Abstract][Full Text] [Related]
4. The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis.
Khanna C; Wan X; Bose S; Cassaday R; Olomu O; Mendoza A; Yeung C; Gorlick R; Hewitt SM; Helman LJ
Nat Med; 2004 Feb; 10(2):182-6. PubMed ID: 14704791
[TBL] [Abstract][Full Text] [Related]
5. Ezrin and moesin expression in canine and feline osteosarcoma.
Hlavaty J; Wolfesberger B; Hauck M; Obermayer-Pietsch B; Fuchs-Baumgartinger A; Miller I; Walter I
Histol Histopathol; 2017 Aug; 32(8):805-816. PubMed ID: 27900754
[TBL] [Abstract][Full Text] [Related]
6. Ezrin Inhibition Up-regulates Stress Response Gene Expression.
Çelik H; Bulut G; Han J; Graham GT; Minas TZ; Conn EJ; Hong SH; Pauly GT; Hayran M; Li X; Özdemirli M; Ayhan A; Rudek MA; Toretsky JA; Üren A
J Biol Chem; 2016 Jun; 291(25):13257-70. PubMed ID: 27137931
[TBL] [Abstract][Full Text] [Related]
7. Beta4 integrin promotes osteosarcoma metastasis and interacts with ezrin.
Wan X; Kim SY; Guenther LM; Mendoza A; Briggs J; Yeung C; Currier D; Zhang H; Mackall C; Li WJ; Tuan RS; Deyrup AT; Khanna C; Helman L
Oncogene; 2009 Sep; 28(38):3401-11. PubMed ID: 19597468
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylated ezrin is located in the nucleus of the osteosarcoma cell.
Di Cristofano C; Leopizzi M; Miraglia A; Sardella B; Moretti V; Ferrara A; Petrozza V; Della Rocca C
Mod Pathol; 2010 Jul; 23(7):1012-20. PubMed ID: 20348881
[TBL] [Abstract][Full Text] [Related]
9. Identification of Novel Ezrin Inhibitors Targeting Metastatic Osteosarcoma by Screening Open Access Malaria Box.
Çelik H; Hong SH; Colón-López DD; Han J; Kont YS; Minas TZ; Swift M; Paige M; Glasgow E; Toretsky JA; Bosch J; Üren A
Mol Cancer Ther; 2015 Nov; 14(11):2497-507. PubMed ID: 26358752
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of microRNA-183/Ezrin axis in judging the prognosis of patients with osteosarcoma.
Mu Y; Zhang H; Che L; Li K
Med Oncol; 2014 Feb; 31(2):821. PubMed ID: 24352761
[TBL] [Abstract][Full Text] [Related]
11. Ezrin in osteosarcoma: comparison between conventional high-grade and central low-grade osteosarcoma.
Park HR; Jung WW; Bacchini P; Bertoni F; Kim YW; Park YK
Pathol Res Pract; 2006; 202(7):509-15. PubMed ID: 16677779
[TBL] [Abstract][Full Text] [Related]
12. P-glycoprotein binds to ezrin at amino acid residues 149-242 in the FERM domain and plays a key role in the multidrug resistance of human osteosarcoma.
Brambilla D; Zamboni S; Federici C; Lugini L; Lozupone F; De Milito A; Cecchetti S; Cianfriglia M; Fais S
Int J Cancer; 2012 Jun; 130(12):2824-34. PubMed ID: 21780101
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of ezrin inhibitors targeting metastatic osteosarcoma.
Paige M; Kosturko G; Bulut G; Miessau M; Rahim S; Toretsky JA; Brown ML; Üren A
Bioorg Med Chem; 2014 Jan; 22(1):478-87. PubMed ID: 24326277
[TBL] [Abstract][Full Text] [Related]
14. The clinical significance of changes in ezrin expression in osteosarcoma of children and young adults.
Lugowska I; Mierzejewska E; Lenarcik M; Klepacka T; Koch I; Michalak E; Szamotulska K
Tumour Biol; 2016 Sep; 37(9):12071-12078. PubMed ID: 27207343
[TBL] [Abstract][Full Text] [Related]
15. Ezrin, a key component in tumor metastasis.
Hunter KW
Trends Mol Med; 2004 May; 10(5):201-4. PubMed ID: 15121044
[TBL] [Abstract][Full Text] [Related]
16. Ezrin and alpha-smooth muscle actin are immunohistochemical prognostic markers in conventional osteosarcomas.
Salas S; Bartoli C; Deville JL; Gaudart J; Fina F; Calisti A; Bollini G; Curvale G; Gentet JC; Duffaud F; Figarella-Branger D; Bouvier C
Virchows Arch; 2007 Dec; 451(6):999-1007. PubMed ID: 17786474
[TBL] [Abstract][Full Text] [Related]
17. Rapamycin inhibits ezrin-mediated metastatic behavior in a murine model of osteosarcoma.
Wan X; Mendoza A; Khanna C; Helman LJ
Cancer Res; 2005 Mar; 65(6):2406-11. PubMed ID: 15781656
[TBL] [Abstract][Full Text] [Related]
18. siRNAs target sites selection of ezrin and the influence of RNA interference on ezrin expression and biological characters of osteosarcoma cells.
Shang X; Wang Y; Zhao Q; Wu K; Li X; Ji X; He R; Zhang W
Mol Cell Biochem; 2012 May; 364(1-2):363-71. PubMed ID: 22286748
[TBL] [Abstract][Full Text] [Related]
19. Small molecule inhibitors of ezrin inhibit the invasive phenotype of osteosarcoma cells.
Bulut G; Hong SH; Chen K; Beauchamp EM; Rahim S; Kosturko GW; Glasgow E; Dakshanamurthy S; Lee HS; Daar I; Toretsky JA; Khanna C; Uren A
Oncogene; 2012 Jan; 31(3):269-81. PubMed ID: 21706056
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase C regulates ezrin-radixin-moesin phosphorylation in canine osteosarcoma cells.
Hong SH; Osborne T; Ren L; Briggs J; Mazcko C; Burkett SS; Khanna C
Vet Comp Oncol; 2011 Sep; 9(3):207-18. PubMed ID: 21848623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
